FDA Device Intelligence
Home › AROA BIOSURGERY LIMITED › OviTex® Core

OviTex® Core

AROA BIOSURGERY LIMITED · Model F10244-1822P · UDI-DI 09421904065055

FTLFTM Prescription
1
510(k) clearances
170,261
Adverse events (862 deaths)
73
Recalls
140
Facilities

Description

The OviTex® Reinforced Tissue Matrix Device is a sterile reinforced matrix device comprised of non-dermal sourced layers of extracellular matrix (ECM) (ovine (sheep) derived ECM), paired with a minimal suture footprint. OviTex Reinforced Tissue Matrix Device provides an alternative device solution to permanent synthetic, resorbable/bioabsorbable synthetic, and biologic meshes. The device remodels and helps regenerate tissue while reinforcing the repair and providing structural support. Reinforced tissue matrices enhance performance while maintaining compatibility with the body. The OviTex Reinforced Tissue Matrix Device is used for hernia repair and abdominal wall reconstruction.

Recalls

DateFirmReason
2024-07-03W.L. Gore & Associates, Inc.Devices were labeled with an expiration date of four years and ten days rather than the validated two years.
2023-04-25Davol, Inc.Balloon may not inflate as intended. If the balloon does not inflate during laparoscopic ventral hernia repair this may result in a delay or prolongation of the procedure, inadequa
2023-04-25Davol, Inc.Balloon may not inflate as intended. If the balloon does not inflate during laparoscopic ventral hernia repair this may result in a delay or prolongation of the procedure, inadequa
2023-04-25Davol, Inc.Balloon may not inflate as intended. If the balloon does not inflate during laparoscopic ventral hernia repair this may result in a delay or prolongation of the procedure, inadequa
2023-04-25Davol, Inc.Balloon may not inflate as intended. If the balloon does not inflate during laparoscopic ventral hernia repair this may result in a delay or prolongation of the procedure, inadequa
2023-01-11Covidien, LPCollagen film was placed on the opposite side of the mesh may cause delay to treatment/therapy, adhesions, erosion/migration, pain, fistula, hernia (recurrence), and failure of imp
2022-08-12Chamberlain Technologies LLCPotential presence of residual adhesive material on the mesh surface.
2022-08-12Chamberlain Technologies LLCPotential presence of residual adhesive material on the mesh surface.
2022-08-12Chamberlain Technologies LLCPotential presence of residual adhesive material on the mesh surface.
2022-08-12Chamberlain Technologies LLCPotential presence of residual adhesive material on the mesh surface.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.